Clinical Nephrotoxins

Renal Injury from Drugs and Chemicals

  • Marc E. de Broe
  • George A. Porter
  • William M. Bennett
  • Gert A. Verpooten

Table of contents

  1. Front Matter
    Pages I-XVII
  2. General

    1. George A. Porter, Biff F. Palmer, William L. Henrich
      Pages 3-20
    2. Françoise Roch-Ramel, Marc E. De Broe
      Pages 21-46
    3. Steve Zlotnick
      Pages 47-50
    4. Lucette Pelletier, Magali Savignac, Philippe Druet
      Pages 51-64
    5. Gur P. Kaushal, Didier Portilla, Judit Megyesi, Peter M. Price, Robert L. Safirstein
      Pages 65-76
    6. Vyacheslav Y. Melnikov, Zoltan H. Endre, Charles L. Edelstein
      Pages 77-114
    7. Paul Jennings, Christian Koppelstätter, Mark J. Helbert, Walter Pfaller
      Pages 115-147
  3. Specific Drugs

    1. Gert A. Verpooten, Paul M. Tulkens, Bruce A. Molitoris
      Pages 151-170
    2. Constantin Cojocel
      Pages 171-198
    3. José F. Bernardo, Ramzi Sabra, Subhash J. Vyas, Robert A. Branch
      Pages 199-222
    4. Carlos A. Vaamonde, Gabriel N. Contreras, Jorge M. Diego
      Pages 223-247
    5. Jeffrey S. Berns, Raphael M. Cohen, Michael R. Rudnick
      Pages 249-262
    6. Monique M. Elseviers, Anke Schwarz, Marc E. de Broe
      Pages 263-278
    7. Andrew Whelton, Til Sturmer, George A. Porter
      Pages 279-306
    8. Jules B. Puschett, Albert W. Dreisbach, Shannan K. Eades
      Pages 339-351
    9. Corinne Isnard-Bagnis, Gilbert Deray
      Pages 353-372
    10. Per-Olof Jarnberg
      Pages 373-381
    11. Cheryl L. Kunis, Harry J. Ward, Gerald B. Appel
      Pages 383-402
    12. Emmanuel A. Burdmann, Luis Yu, Takeshi F. Andoh, Norberto Perico, William M. Bennett
      Pages 403-458
    13. Daniel Abramowicz, Mary Meyer, Sandrine Florquin, Michel Goldman
      Pages 459-482
    14. Christiane M. Erley, George A. Porter
      Pages 483-494
    15. Richard P. Wedeen, Bryan T. Emmerson
      Pages 495-506
    16. Teruhiko Kido, Gunnar F. Nordberg, Harry A. Roels
      Pages 507-530
    17. Carl-Gustaf Elinder, Bruce A. Fowler, Margaret H. Whittaker
      Pages 531-544
    18. Patrick C. D’haese, Monique M. Elseviers, Muhammed Yaqoob, Marc E. De Broe
      Pages 545-558
    19. Parveen Naaz, Edgar V. Lerma, Daniel C. Batlle
      Pages 559-578
    20. Jean-Louis Vanherweghem, Frederic Debelle, Marie-Carmen Muniz-Martinez, Joëlle Nortier
      Pages 579-586
    21. Ljubica Djukanović, Zoran Radovanović
      Pages 587-601
    22. Charles Swanepoel, Sarala Naicker, Rafique Moosa, Ivor Katz, Salma M. Suleiman, Majid Twahir
      Pages 603-610
    23. Mohamed I. Hamdouk, Salma M. Suleiman, Hatem Kallel, Mounir Bouaziz, Said Moutaouakkil, Marc E. De Broe et al.
      Pages 611-618
  4. Prevention

    1. William F. Finn, George A. Porter
      Pages 621-655
    2. Gert A. Verpooten, Philippe Jorens, Marcus M. Reidenberg
      Pages 657-666
    3. Ali J. Olyaei, Angelo M. Demattos, William M. Bennett
      Pages 667-679
  5. Back Matter
    Pages 681-712

About this book


To you the reader, the joy of discovery begins, for We continue in our goal of providing a text which us the job is done. In this edition, we have corrected is useful, not only to the clinician, but of equal interest past deficiencies, added new topics, expanded infor- to the investigator. The selection of content has been mation regarding the pediatric age group, provided directed at topics of current interest rather than those up to date (March 2003) references, while remaining of historic contribution. We have stressed the cont- true to our concept of a multi-national author book. bution of cell biology and pathophysiology, were it We continue to believe that scientific information is an exists, believing it provides both a better understa- international commodity whose interpretation and ap- ing of toxic injury when known, and a rational dir- plication are strongly influenced by both the cultural tion for therapy and prevention. and ethnic background of the observer. The oppor- nity to share in the rich diversity of the international We are encouraged by the accumulation of rec- scientific community remains a fundamental goal of nized risk factors, which allow pre-treatment strati- this endeavor. To participate as equals leads to mu- cation of our patients’ relative risk and allow us to - tual respect and peer appreciation. The sharing of in- cus our preventative techniques on the individuals tellectual resources fostered by this effort should and most likely to gain the greatest benefit.


biology pathophysiology physiology prevention

Editors and affiliations

  • Marc E. de Broe
    • 1
  • George A. Porter
    • 2
  • William M. Bennett
    • 3
  • Gert A. Verpooten
    • 4
  1. 1.Department of Nephrology and HypertensionUniversity of AntwerpBelgium
  2. 2.Department of MedicineThe Oregon Health Sciences UniversityPortlandUSA
  3. 3.Northwest Renal ClinicLegacy Good Samaritan HospitalPortlandUSA
  4. 4.Department of Nephrology and HypertensionUniversity of AntwerpBelgium

Bibliographic information

  • DOI
  • Copyright Information Springer Science + Business Media, Inc. 2003
  • Publisher Name Springer, Dordrecht
  • eBook Packages Springer Book Archive
  • Print ISBN 978-1-4020-1277-8
  • Online ISBN 978-1-4020-2586-0
  • Buy this book on publisher's site